Vertex Pharmaceuticals
VRTX
#173
Rank
NZ$224.29 B
Marketcap
NZ$883.73
Share price
1.69%
Change (1 day)
20.37%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): NZ$8.64 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$12.21 Billion. In 2025 the company made an earning of NZ$8.76 Billion, an increase over its 2024 earnings that were of NZ$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$8.64 B-1.39%
2025 NZ$8.76 B1675.06%
2024 NZ$0.49 B-93.69%
2023 NZ$7.82 B3.19%
2022 NZ$7.58 B53.56%
2021 NZ$4.93 B-12.06%
2020 NZ$5.61 B118.45%
2019 NZ$2.57 B120.64%
2018 NZ$1.16 B1473.64%
2017 NZ$74.03 M197.6%
2016 NZ$24.87 M-102.97%
2015 -NZ$0.84 Billion-28.46%
2014 -NZ$1.18 Billion-51.5%
2013 -NZ$2.42 Billion-30584.68%
2012 NZ$7.92 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.05 Billion
2007 -NZ$0.73 Billion83.1%
2006 -NZ$0.4 Billion59.02%
2005 -NZ$0.26 Billion3.28%
2004 -NZ$0.25 Billion-38.16%
2003 -NZ$0.4 Billion
2000 -NZ$67.29 Million-20.38%
1999 -NZ$84.51 Million31.62%
1998 -NZ$64.21 Million91.05%
1997 -NZ$33.61 Million-36.24%
1996 -NZ$52.71 Million12.45%
1995 -NZ$46.88 Million27.4%
1994 -NZ$36.79 Million-1833.33%
1993 NZ$2.12 M-112.12%
1992 -NZ$17.52 Million175%
1991 -NZ$6.37 Million-12.2%
1990 -NZ$7.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.94 B 413.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.66 B 30.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.32 B 93.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.26 B 159.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.97 B 89.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$0.14 Billion-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA